drug
arimoclomol citrate
Marketedupdated 5mo agoby $ZVRA ZEVRA THERAPEUTICS, INC.
Approvedcommunity read0 votes
all catalysts(0)
nothing on the calendar yet
Patent cliff
source: FDA Orange Bookfirst barrier falls
Jun 26, 2029
~2.7 years out
Earliest of all listed patents + FDA exclusivities. Generic / biosimilar entry typically only becomes possible AFTER both patent and exclusivity barriers expire.
patents (12)
- Aug 19, 2029method-of-use (U-4021)US 110454602.9y
- Aug 19, 2029method-of-use (U-4021)US 110454602.9y
- Aug 19, 2029method-of-use (U-4021)US 110454602.9y
- Aug 19, 2029method-of-use (U-4021)US 110454602.9y
- Aug 11, 2029method-of-use (U-4021)US 92894722.9y
- Aug 11, 2029method-of-use (U-4021)US 92894722.9y
- Aug 11, 2029method-of-use (U-4021)US 92894722.9y
- Aug 11, 2029method-of-use (U-4021)US 92894722.9y
- Jun 26, 2029method-of-use (U-4021)US 98840582.7y
- Jun 26, 2029method-of-use (U-4021)US 98840582.7y
- Jun 26, 2029method-of-use (U-4021)US 98840582.7y
- Jun 26, 2029method-of-use (U-4021)US 98840582.7y
FDA exclusivities (8)
- Sep 20, 2031ODE-496Orphan Drug (7y)5.0y
- Sep 20, 2031ODE-496Orphan Drug (7y)5.0y
- Sep 20, 2031ODE-496Orphan Drug (7y)5.0y
- Sep 20, 2031ODE-496Orphan Drug (7y)5.0y
- Sep 20, 2029NCENew Chemical Entity (5y)3.0y
- Sep 20, 2029NCENew Chemical Entity (5y)3.0y
- Sep 20, 2029NCENew Chemical Entity (5y)3.0y
- Sep 20, 2029NCENew Chemical Entity (5y)3.0y
News(0)
no news has mentioned this drug yet
Data sources
last refreshed 5m ago
Found something off?
comments(0)
5-min edit window · permanent after that